13F Filings History of Nuveen Fund Advisors, LLC

Latest 13F report
Q4 2025 - 12 Feb 2026
Signature - Title
Erik Mogavero - Chief Compliance Officer
Location
Chicago, IL
Summary
This page shows a list of all the recent 13F filings made by Nuveen Fund Advisors, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Nuveen Fund Advisors, LLC reported 1 stock holding with total value $239,000 as of Q1 2019. Nuveen, LLC is reporting for Nuveen Fund Advisors, LLC.

Notify me when Nuveen Fund Advisors, LLC files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value

Nuveen, LLC is reporting for Nuveen Fund Advisors, LLC:

Name Holdings Value Location File Number
Nuveen, LLC $381,899,026,358 Charlotte, NC 028-25561
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q4 2025 $0 13F-NT 22 Jan 2026, 06:38
Q3 2025 $0 13F-NT 06 Oct 2025, 11:14
Q2 2025 $0 13F-NT 05 Aug 2025, 10:17
Q1 2025 $0 13F-NT 12 May 2025, 07:51
Q4 2024 $0 13F-NT 10 Feb 2025, 10:13
Q3 2024 $0 13F-NT 08 Nov 2024, 15:19
Q2 2024 $0 13F-NT 09 Aug 2024, 13:24
Q1 2024 $0 13F-NT 10 May 2024, 10:12
Q4 2023 $0 13F-NT 14 Feb 2024, 07:01
Q3 2023 0 $0 13F-NT 14 Nov 2023, 06:16
Q2 2023 0 $0 13F-NT 14 Aug 2023, 07:00
Q1 2023 0 $0 13F-NT 12 May 2023, 06:15
Q4 2022 0 $0 13F-NT 14 Feb 2023, 06:30
Q3 2022 0 $0 13F-NT 14 Nov 2022, 06:21
Q2 2022 0 $0 13F-NT 15 Aug 2022, 11:44
Q1 2022 0 $0 13F-NT 16 May 2022, 10:42
Q4 2021 0 $0 13F-NT 14 Feb 2022, 08:39
Q3 2021 0 $0 13F-NT 12 Nov 2021, 13:42
Q2 2021 0 $0 13F-NT 16 Aug 2021, 07:00
Q1 2021 0 $0 13F-NT 17 May 2021, 19:08
Q4 2020 0 $0 13F-NT 16 Feb 2021, 06:00
Q3 2020 0 $0 13F-NT 13 Nov 2020, 13:09
Q2 2020 0 $0 13F-NT 13 Nov 2020, 13:14
Q1 2020 0 $0 13F-NT 13 Nov 2020, 13:17
Q4 2019 0 $0 13F-NT 13 Nov 2020, 13:18
Q3 2019 0 $0 $0 $0 $0 13F-HR 14 Nov 2019, 11:29
Q2 2019 0 $0 $0 -$239,000 -$239,000 13F-HR 14 Aug 2019, 14:20
Q1 2019 1 $239,000 $0 -$11,171,026 -$11,171,026 CSCO 13F-HR 14 May 2019, 14:05
Q4 2018 45 $11,281,000 $0 -$29,788,532 -$29,788,532 CSCO, AMZN, JNJ, NVDA, V 13F-HR 14 Feb 2019, 16:51
Q3 2018 119 $45,005,000 +$245,000 -$40,533,934 -$40,288,934 NVDA, CSCO, ARCC, AMZN, GSK 13F-HR 13 Nov 2018, 13:32
Q2 2018 170 $81,071,000 +$146,000 -$141,697,352 -$141,551,352 NVDA, CSCO, ARCC, META, GSK 13F-HR 14 Aug 2018, 14:47
Q1 2018 250 $217,113,000 +$1,613,722 -$120,781,938 -$119,168,216 HPQ, AMGN, CSCO, BAC, WMT 13F-HR 14 May 2018, 15:03
Q4 2017 310 $345,173,000 +$1,693,882 -$172,254,677 -$170,560,795 WMT, HPQ, AMGN, GM, BAC 13F-HR 14 Feb 2018, 14:58
Q3 2017 354 $491,541,000 +$2,443,000 -$158,740,994 -$156,297,994 AMGN, VZ, HPQ, GM, GILD 13F-HR 14 Nov 2017, 12:57
Q2 2017 420 $623,979,000 +$26,493,835 -$164,739,097 -$138,245,262 VZ, AMGN, GM, BA, F 13F-HR 14 Aug 2017, 15:09
Q1 2017 441 $756,369,000 +$120,241,758 -$80,085,456 +$40,156,302 VZ, CSCO, BA, GM, F 13F-HR 15 May 2017, 15:00
Q4 2016 451 $692,459,000 +$66,151,245 -$98,730,865 -$32,579,620 VZ, BA, CSCO, MCD, GM 13F-HR 14 Feb 2017, 14:59
Q3 2016 464 $717,240,000 +$91,281,611 -$39,989,085 +$51,292,526 VZ, CSCO, BA, AMGN, AAPL 13F-HR 14 Nov 2016, 17:21
Q2 2016 445 $646,790,000 $0 $0 $0 VZ, BA, PFE, AMGN, GILD 13F-HR 12 Aug 2016, 13:46
Q1 2016 0 $0 13F-NT 13 May 2016, 17:11
Q4 2015 0 $0 13F-NT 11 Feb 2016, 16:25
Q3 2015 0 $0 13F-NT 13 Nov 2015, 15:47
Q2 2015 0 $0 13F-NT 14 Aug 2015, 15:04
Q1 2015 0 $0 13F-NT 15 May 2015, 11:20
Q4 2014 0 $0 13F-NT 12 Feb 2015, 14:55
Q3 2014 0 $0 13F-NT 13 Nov 2014, 13:22
Q2 2014 0 $0 13F-NT 14 Aug 2014, 14:19
Q1 2014 0 $0 13F-NT 12 May 2014, 17:36
Q4 2013 0 $0 13F-NT 07 Feb 2014, 13:56